Bridgefront Capital’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-6,877
Closed -$549K 1011
2021
Q1
$549K Buy
+6,877
New +$537K 0.17% 192

Bridgefront Capital's CMD Position: Q2 2021 in Review

Bridgefront Capital sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 6,877 shares — an estimated $549K sold.

Bridgefront Capital first reported a position in CMD in Q1 2021 and held it in 1 quarter. The position peaked at $549K in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

  • Bridgefront Capital reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
  • Bridgefront Capital sold 6,877 Cantel Medical Corporation shares in Q2 2021, an estimated $549K.
  • Bridgefront Capital first reported a position in Cantel Medical Corporation in Q1 2021 and held it in 1 quarter.
  • Bridgefront Capital's Cantel Medical Corporation position peaked at $549K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Bridgefront Capital's 13F filing for Q2 2021, filed 12 Aug 2021.